The DOI matches its Crossref record; 191 of the 193 references it cites were found in a registry or an index.
Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy
Open accessAbstract
Idiopathic inflammatory myopathies (IIMs), which are a group of chronic and diverse inflammatory diseases, are primarily characterized by weakness in the proximal muscles that progressively leads to persistent disability. Current treatments of IIMs depend on nonspecific immunosuppressive agents (including glucocorticoids and immunosuppressants). However, these therapies sometimes fail to regulate muscle inflammation, and some patients suffer from infectious diseases and other adverse effects related to the treatment. Furthermore, even after inflammation has subsided, muscle weakness persists in a significant proportion of the patients. Therefore, the elucidation of pathophysiology of IIMs and development of a better therapeutic strategy that not only alleviates muscle inflammation but also improves muscle weakness without increment of opportunistic infection is awaited. Muscle fiber death, which has been formerly postulated as “necrosis”, is a key histological feature of all subtypes of IIMs, however, its detailed mechanisms and contribution to the pathophysiology remained to be elucidated. Recent studies have revealed that muscle fibers of IIMs undergo necroptosis, a newly recognized form of regulated cell death, and promote muscle inflammation and dysfunction through releasing inflammatory mediators such as damage-associated molecular patterns (DAMPs). The research on murine model of polymyositis, a subtype of IIM, revealed that the inhibition of necroptosis or HMGB1, one of major DAMPs released from muscle fibers undergoing necroptosis, ameliorated muscle inflammation and recovered muscle weakness. Furthermore, not only the necroptosis-associated molecules but also PGAM5, a mitochondrial protein, and reactive oxygen species have been shown to be involved in muscle fiber necroptosis, indicating the multiple target candidates for the treatment of IIMs acting through necroptosis regulation. This article overviews the research on muscle injury mechanisms in IIMs focusing on the contribution of necroptosis in their pathophysiology and discusses the potential treatment strategy targeting muscle fiber necroptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Next, PF1801 exerts its effects by activating AMP-activated protein kinase (AMPK).382”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [382]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Through this sophisticated molecular regulation, PF1801 not only alleviates inflammation and necrosis in muscle fibers but also enhances the energy and antioxidant status of muscle cells.382”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [382]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691 · cited 1×
“Such “regulated necrosis” includes necroptosis (19, 20), pyroptosis (94, 95), and ferroptosis (96).”
BackgroundApoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · cited 1×
“Therefore, in addition to the presence of cleaved CASP3, DNA fragmentation, which can be detected using terminal deoxynucleotidyl transferase nick-end labeling (TUNEL) or gel electrophoresis (78, 79), has been widely utilized as a surrogate marker for apoptosis.”
BackgroundGalluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · cited 18×
“RIPK1 and RIPK3 are cleaved and inactivated by the proteolytic activity of caspases, including CASP8 (118, 119), therefore, inactivation or absence of CASP8 is necessary for the execution of necroptosis.”
BackgroundInfluentialPolymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
SATELLITE CELL OF SKELETAL MUSCLE FIBERS
Mauro, A. (1961) · The Journal of Cell Biology · doi:10.1083/jcb.9.2.493 · Cited by 3,683
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068 · cited 3×
“Such “regulated necrosis” includes necroptosis (19, 20), pyroptosis (94, 95), and ferroptosis (96).”
BackgroundMixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
The molecular machinery of regulated cell death
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0164-5 · Cited by 2,549 · cited 1×
“Recent studies have demonstrated the effectiveness of targeting regulated necrosis in models of inflammatory or degenerative diseases (97, 98).”
BackgroundHigh-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Diabetes-induced muscle wasting: molecular mechanisms and promising therapeutic targets
Qiao, R., Guo, J., Zhang, C., Wang, S., Fang, J., Geng, R., Kang, S., Huang, K., & Tong, T. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2382348 · Cited by 18
“In addition to ferroptosis, other forms of regulated necrosis, such as pyro-ptosis and necroptosis, have also been associated with muscle wasting (Jin et al. 2022; Kamiya et al. 2023).”
Gong, J., Hong-yi, X., Shen, Y., Gao, Z., Ji, Y., Yao, X., Sun, J., Dai, B., & Sun, H. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179208 · Cited by 9
Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
Nasonov, E. L., Паневин, Т. С., & Troshina, E. A. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2024-135-144 · Cited by 8
The role of cell death in the physiological and pathological processes of skeletal muscle
Hong-yi, X., Gao, Z., Yao, X., Sun, J., & Chen, B. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1717233 · Cited by 9
Metadata
- Authors
- Kamiya, M., Kimura, N., Umezawa, N., Hasegawa, H., & Yasuda, S.
- Affiliations
- Tokyo Medical and Dental University (JP)
- Corresponding author
- Yasuda, Shinsuke
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2023-07-07
- Volume
- 14
- Pages
- 1191815-1191815
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC10361824
- OpenAlex
- W4383534034
- Cited by
- 21
- References
- 193
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 5
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Rheumatology › Inflammatory Myopathies and Dermatomyositis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- idiopathic inflammatory myopathies, polymyositis, HMGB1, damage-associated molecular patterns, PGAM5, reactive oxygen species, muscle inflammation, muscle weakness, regulated cell death, therapeutic target
- MeSH terms
- Necroptosis, Animals, Humans, Inflammation, Myositis, Muscle Fibers, Skeletal, Muscle Weakness, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy. https://app.cochat.ai/papers/10.3389/fimmu.2023.1191815
- The paper
- Kamiya, M., Kimura, N., Umezawa, N., Hasegawa, H., & Yasuda, S. (2023). Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1191815
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.